QIAGEN N.V.
QGEN
$47.75
-$0.35-0.73%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.32% | 5.15% | 3.31% | 0.66% | 0.62% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.32% | 5.15% | 3.31% | 0.66% | 0.62% |
| Cost of Revenue | -26.19% | -25.63% | 45.64% | 42.19% | 45.69% |
| Gross Profit | 35.08% | 33.89% | -18.40% | -20.70% | -22.13% |
| SG&A Expenses | 0.51% | 0.18% | -1.17% | -2.56% | -3.20% |
| Depreciation & Amortization | -14.24% | -16.74% | -13.94% | -9.10% | -7.31% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.52% | -14.73% | 18.27% | 16.77% | 17.70% |
| Operating Income | 201.97% | 216.83% | -47.51% | -54.36% | -58.74% |
| Income Before Tax | 344.03% | 400.98% | -67.30% | -71.81% | -72.61% |
| Income Tax Expenses | 378.27% | 363.95% | -48.21% | -57.57% | -74.80% |
| Earnings from Continuing Operations | 336.20% | 413.63% | -72.20% | -75.51% | -72.05% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 336.20% | 413.63% | -72.20% | -75.51% | -72.05% |
| EBIT | 201.97% | 216.83% | -47.51% | -54.36% | -58.74% |
| EBITDA | 90.87% | 92.93% | -35.42% | -38.41% | -40.45% |
| EPS Basic | 340.57% | 419.21% | -72.73% | -76.00% | -72.55% |
| Normalized Basic EPS | 173.30% | 185.53% | -44.79% | -51.74% | -53.96% |
| EPS Diluted | 346.58% | 428.53% | -73.45% | -76.35% | -72.95% |
| Normalized Diluted EPS | 174.73% | 187.53% | -44.81% | -51.84% | -54.08% |
| Average Basic Shares Outstanding | 0.32% | 0.34% | 0.31% | 0.54% | 0.53% |
| Average Diluted Shares Outstanding | 0.38% | 0.35% | -0.10% | 0.23% | 0.22% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |